Sort
130,381 grants matching “hiv”
Immunopathogenesis of HIV Neurological Disorders
$1,257,632University Of Puerto Rico Med Sciences · U54 · FY2004 · NS
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles
$1,257,527Dimiter S Dimitrov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
St. Jude/Memphis IMPAACT Clinical Trials Unit
$1,257,366Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2007 · AI
NATURAL HISTORY OF MENOPAUSE IN HIV INFECTED DRUG USERS
$1,257,361Montefiore Medical Center (Bronx, Ny) · R01 · FY2003 · DA
Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI)
$1,257,262Mackfallen Giliadi Anasel · Centre Of Excellence In Health Monitoring And Evaluation · UG1 · FY2023 · HD
Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy
$1,257,182Mauricio De Aguiar Martins · University Of Florida · U01 · FY2025 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,257,077Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2025 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$1,256,929Bernard Moss · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
WOMEN AND INFANTS TRANSMISSION STUDY (WITS III)
$1,256,636Columbia University Health Sciences · U01 · FY2000 · DA
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$1,256,490Barry Coller · Rockefeller University · UL1 · FY2007 · RR
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,256,450Mark Middleton · Starks Associates, Inc. · N01 · FY2021 · AI
Crosstalk Among Oral & Gastrointestinal Soluble Innate Factors, HIV, & Microbes
$1,256,065Daniel Malamud · New York University · U19 · FY2008 · DE
STRUCTURE-BASED DESIGN PARADIGM:HIV Tat.PCAF INHIBITORS
$1,255,985Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · GM
Adjuvant Discovery For Diphtheria Toxin Vaccine and Zika Vaccine
$1,255,650Sunil David · University Of Kansas Lawrence · N01 · FY2018 · AI
Non Human Primate Models of SIV and HIV Immune Protection
$1,255,483John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
HIV/AIDS Vaccine Development
$1,255,483John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2017 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2015 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2016 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2018 · AI
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
$1,255,386Lisa R Metsch · University Of Miami School Of Medicine · R01 · FY2011 · DA
UW Clinical HIV Integrated Research Program
$1,255,138Ann Cornwall Collier · University Of Washington · UM1 · FY2012 · AI
Gene Transfer into Hematopoietic Stem Cells
$1,255,124Fabio Candotti · Human Genome Research · Z01 · FY2007 · HG
NORTH JERSEY COMMUNITY RESEARCH INITIATIVE (NJCRI)
$1,255,059North Jersey Aids Alliance ,Inc. (Njcri) · U01 · FY2003 · AI
NORTH JERSEY COMMUNITY RESEARCH INITIATIVE (NJCRI)
$1,255,059North Jersey Aids Alliance ,Inc. (Njcri) · U01 · FY2004 · AI